Advertisement

Current Listing System

  • Deirdre M. Mooney
  • Marwa SabeEmail author
Living reference work entry
Part of the Organ and Tissue Transplantation book series (OTT)

Abstract

The United Network of Organ Sharing (UNOS) is the Organ Procurement and Transplantation Network (OPTN) that oversees heart transplantation in the United States. In 2016, a 10-year update to the 2006 International Listing Criteria for Heart Transplantation was published by the International Society for Heart and Lung Transplantation (ISHLT). Criteria were revised to reflect advances in the management of advanced heart failure patients, incorporate evidence from interval landmark trials, and specifically address patients with congenital heart disease, restrictive or infiltrative cardiomyopathy, and chronic infectious disease. Notable updates include frailty assessment, use of mechanical circulatory support as a bridge for candidacy, prioritization of highly sensitized patients, retransplantation for severe chronic allograft vasculopathy, removal of allocation algorithms that allowed for prioritization of higher-status patients within larger geographic areas, lower suggested cutoff values for minimal estimated glomerular filtration rate, assessment of the adequacy of social support in potential transplant candidates, and the role of heart failure prognosis scores in ambulatory patients. Three sections provide guidance on patients that may be less responsive to traditional pharmacologic and device-based therapies and/or have unique challenges with respect to support prior to transplant and posttransplant management. The OPTN policy on allocation of donor hearts was most recently revised in 2018.

Keywords

Listing criteria for heart transplantation Heart transplant candidate International Society for Heart and Lung Transplantation (ISHLT) Advanced heart failure United Network for Organ Sharing (UNOS) Organ Procurement and Transplantation Network (OPTN) Adult heart status Mechanical circulatory support 

List of Abbreviations

AHS

Adult heart status

CMS

Centers for Medicare and Medicaid Services

DSA

Donor-specific area

OPO

Organ procurement organization

References

  1. About the OPTN. U.S. Department of Health & Human Services. https://optn.transplant.hrsa.gov/governance/about-the-optn/. Accessed 10 May 2017
  2. Adult Heart Allocation Changes (2016) U.S. Department of Health & Human Services. https://optn.transplant.hrsa.gov/governance/public-comment/adult-heart-allocation-changes-2016/. Accessed 10 May 2017
  3. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA (2004) Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J 147:354–360CrossRefGoogle Scholar
  4. Corbett C, Armstrong MJ, Neuberger J (2012) Tobacco smoking and solid organ transplantation. Transplantation 94:979–987CrossRefGoogle Scholar
  5. Duerinckx N, Burkhalter H, Engberg SJ, Kirsch M, Klem ML, Sereika SM, De Simone P, De Geest S, Dobbels F, B. Serious Consortium (2016) Correlates and outcomes of posttransplant smoking in solid organ transplant recipients: a systematic literature review and meta-analysis. Transplantation 100:2252–2263CrossRefGoogle Scholar
  6. History of UNOS. United Network for organ sharing. https://www.unos.org/about/history-of-unos/. Accessed 10 May 2017
  7. Houston BA, Kalathiya RJ, Stevens GR, Russell SD, Tedford RJ (2015) One-and-done: do left ventricular assist device patients on the transplant list really need frequent right heart catheterization assessments for pulmonary hypertension? J Heart Lung Transplant 34:1637–1639CrossRefGoogle Scholar
  8. Khanna AK, Xu J, Uber PA, Burke AP, Baquet C, Mehra MR (2009) Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss. Circulation 120:1814–1821CrossRefGoogle Scholar
  9. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR (1991) Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778–786CrossRefGoogle Scholar
  10. Mehra MR, Canter CE, Hannan MM, Semigran MJ, Uber PA, Baran DA, Danziger-Isakov L, Kirklin JK, Kirk R, Kushwaha SS, Lund LH, Potena L, Ross HJ, Taylor DO, Verschuuren EA, Zuckermann A, Council International Society for Heart Lung Transplantation Infectious Diseases, Council International Society for Heart Lung Transplantation Pediatric Transplantation, Failure International Society for Heart Lung Transplantation Heart, Council Transplantation (2016) The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update. J Heart Lung Transplant 35:1–23CrossRefGoogle Scholar
  11. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M (2006) Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates – 2006. J Heart Lung Transplant 25:1024–1042CrossRefGoogle Scholar
  12. Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME Jr, Stevenson LW (1993) 24th Bethesda conference: cardiac transplantation. Task Force 3: recipient guidelines/prioritization. J Am Coll Cardiol 22:21–31CrossRefGoogle Scholar
  13. Myers J, Arena R, Oliveira RB, Bensimhon D, Hsu L, Chase P, Guazzi M, Brubaker P, Moore B, Kitzman D, Peberdy MA (2009) The lowest VE/VCO2 ratio during exercise as a predictor of outcomes in patients with heart failure. J Card Fail 15:756–762CrossRefGoogle Scholar
  14. Nicholls M (2014) The 2014 ESC guidelines on the diagnosis and management of hypertrophic cardiomyopathy have been published. Eur Heart J 35:2849–2850CrossRefGoogle Scholar
  15. OPTN. Guidance regarding adult heart status 1A(b) device-related complications. Organ Procurement & Transplantation Network, U.S. Department of Health & Human Services. https://optn.transplant.hrsa.gov/resources/guidance/guidance-regarding-adult-heart-status-1a-b-device-related-complications/. Accessed 24 August
  16. Organ Procurement and Transplantation Network Policies. Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/media/1200/optn_policies.pdf - nameddest=Policy_06. Accessed 5 May 2019
  17. Organ Procurement and Transplantation Network: guidance regarding adult heart status 1A(b) device-related complications. U.S. Department of Health & Human Services. https://optn.transplant.hrsa.gov/resources/guidance/guidance-regarding-adult-heart-status-1a-b-device-related-complications/. Accessed 10 May 2017
  18. Patel SR, Saeed O, Naftel D, Myers S, Kirklin J, Jorde UP, Goldstein DJ (2017) Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: an INTERMACS analysis. J Card Fail 23:859–867CrossRefGoogle Scholar
  19. Peterson LR, Schechtman KB, Ewald GA, Geltman EM, de las Fuentes L, Meyer T, Krekeler P, Moore ML, Rogers JG (2003) Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. J Heart Lung Transplant 22:1141–1148CrossRefGoogle Scholar
  20. Russo MJ, Hong KN, Davies RR, Chen JM, Mancini DM, Oz MC, Rose EA, Gelijns A, Naka Y (2010) The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines? Ann Surg 251:144–152CrossRefGoogle Scholar
  21. Subramanian AK, Morris MI, A. S. T. Infectious Diseases Community of Practice (2013) Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant 13(Suppl 4):68–76CrossRefGoogle Scholar
  22. Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, Joyce LD, Park SJ (2011) Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 4:266–275CrossRefGoogle Scholar
  23. United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment (1984) National Organ Transplant Act: hearings before the subcommittee on Health and the environment of the committee on energy and commerce, house of representatives, ninety-eighth congress, first session, on H.R. 4080 … July 29, October 17 and 31, 1983. United States Government Publishing Office, Washington, DCGoogle Scholar
  24. Weiss ES, Allen JG, Russell SD, Shah AS, Conte JV (2009) Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation. J Heart Lung Transplant 28:1150–1157CrossRefGoogle Scholar
  25. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147–e239CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Center for Advanced Heart Disease & TransplantProvidence Spokane Heart InstituteSpokaneUSA
  2. 2.Advanced Heart Failure ProgramBeth Israel Deaconess Medical Center, Harvard Medical SchoolBostonUSA

Personalised recommendations